These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 28138752)

  • 1. [Sudden bilateral decreased vision in a 14-year-old boy].
    Marx S; Scheuerle A; Khoramnia R; Tandogan T; Kaiser D; Auffarth GU; Sel S
    Ophthalmologe; 2017 Aug; 114(8):748-750. PubMed ID: 28138752
    [No Abstract]   [Full Text] [Related]  

  • 2. Massive retinal infiltrates as the presenting sign of chronic myeloid leukemia: Clinical and imaging features of leukemic retinopathy.
    Szeto SK; Mohamed S; Tsang CW; Chan CK
    Eur J Ophthalmol; 2023 Jan; 33(1):NP55-NP63. PubMed ID: 34595942
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Acute bilateral visual impairment after a viral infection].
    Mischke M; Schilimow A; Varde MA; Wiechens B
    Ophthalmologe; 2017 Aug; 114(8):751-754. PubMed ID: 28194487
    [No Abstract]   [Full Text] [Related]  

  • 4. Optic coherence tomography of foveal hemorrhage associated with chronic myelogenous leukemia.
    Hori S; Yamamoto K
    Retina; 2015 Mar; 35(3):597-9. PubMed ID: 25046396
    [No Abstract]   [Full Text] [Related]  

  • 5. Blurred vision and epistaxis.
    Shirley K; McNicholl FP
    BMJ; 2014 Jan; 348():g91. PubMed ID: 24445968
    [No Abstract]   [Full Text] [Related]  

  • 6. Retinal haemorrhages: a clue to the underlying leukaemia.
    Tyagi M; Agarwal K; Paulose RM; Rani PK
    BMJ Case Rep; 2017 Sep; 2017():. PubMed ID: 28951507
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Blurring of vision as the only symptom in an undiagnosed case of chronic myeloid leukemia in the COVID-19 era.
    Gumaste P; Vairagyam R
    Indian J Ophthalmol; 2021 Mar; 69(3):768-769. PubMed ID: 33595523
    [No Abstract]   [Full Text] [Related]  

  • 8. Chronic myeloid leukemia presenting with bilateral central retinal vein occlusion and massive retinal infiltrates.
    Goel N; Pangtey B; Thakar M; Raina UK; Ghosh B
    J AAPOS; 2012 Aug; 16(4):406-8. PubMed ID: 22929456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bilateral Central Retinal Vein Occlusion as Presenting Feature of Chronic Myeloid Leukemia.
    Narang S; Gupta P; Sharma A; Sood S; Palta A; Goyal S
    Middle East Afr J Ophthalmol; 2016; 23(3):253-5. PubMed ID: 27555710
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic and therapeutic challenges.
    McDonald HR
    Retina; 2002 Dec; 22(6):779-83. PubMed ID: 12476106
    [No Abstract]   [Full Text] [Related]  

  • 11. Case 3: Priapism in a 13-year-old Boy.
    Clark AJ; Hsu P; Darves-Bornoz A; Tanaka ST; Mason EF; Katzenstein HM
    Pediatr Rev; 2018 Dec; 39(12):617-619. PubMed ID: 30504255
    [No Abstract]   [Full Text] [Related]  

  • 12. Diagnostic and therapeutic challenges.
    Buettner H; Pesin SR; Hasan SJ; MacCumber M; Blodi BA
    Retina; 2005 Jun; 25(4):510-4. PubMed ID: 15933600
    [No Abstract]   [Full Text] [Related]  

  • 13. Resolution of Roth spots in chronic myeloid leukaemia after treatment with imatinib.
    Docherty SM; Reza M; Turner G; Bowles K
    Br J Haematol; 2015 Sep; 170(6):744. PubMed ID: 26119417
    [No Abstract]   [Full Text] [Related]  

  • 14. The Importance of Being Cured: A Chronic Myeloid Leukemia Perspective.
    Raanani P
    Acta Haematol; 2016; 135(3):131-2. PubMed ID: 26535978
    [No Abstract]   [Full Text] [Related]  

  • 15. Ophthalmic manifestations in hepatitis-associated aplastic anemia (HAAA): Case report.
    Lezrek O; Albaroudi N; Tijani M; Daoudi C; Benchekroun Belabbes I; Khattab M; Tachfouti S; Boutimzine N; Daoudi R
    J Fr Ophtalmol; 2017 Jun; 40(6):e231-e233. PubMed ID: 28579381
    [No Abstract]   [Full Text] [Related]  

  • 16. [Imatinib is effective in a 12-month-old boy with chronic myelogenous leukemia: case report and literature review].
    Pan Y; Wen S; Tian J; Lyu Z; Du Z; Yan L
    Zhonghua Er Ke Za Zhi; 2015 Mar; 53(3):194-7. PubMed ID: 26165016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Emergence of del(20q) in a patient in molecular remission of chronic myelogenous leukemia during imatinib treatment, with reduction following imatinib discontinuation.
    Numata A; Kajiyama R; Itabashi M; Ishii Y; Yamamoto W; Motohashi K; Matsumoto K; Hagihara M; Ishigatsubo Y; Fujisawa S
    Leuk Lymphoma; 2016; 57(1):201-2. PubMed ID: 25860242
    [No Abstract]   [Full Text] [Related]  

  • 18. A rare case of chronic myelogenous leukemia and plasma cell myeloma in the same patient.
    Ahn S; Park JS; Han JH; Cho SR
    Ann Lab Med; 2015 May; 35(3):370-2. PubMed ID: 25932449
    [No Abstract]   [Full Text] [Related]  

  • 19. [Case of pediatric chronic myeloid leukemia with bilateral visual loss onset].
    Hara Y; Kamura Y; Oikawa A; Shichino H; Mugishima H; Goto H
    Nippon Ganka Gakkai Zasshi; 2010 May; 114(5):459-63. PubMed ID: 20545220
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imatinib-induced optic neuritis in a patient of chronic myeloid leukemia.
    Govind Babu K; Attili VS; Bapsy PP; Anupama G
    Int Ophthalmol; 2007 Feb; 27(1):43-4. PubMed ID: 17410337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.